Exogenous angiotensin II does not facilitate norepinephrine release in the heart

Hypertension

Volumn 40, Issue 4, 2002, Pages 491-497

  Lameris, Thomas W ^a   De Zeeuw, Sandra ^a   Duncker, Dirk J ^a   Alberts, Gooitzen ^a   Boomsma, Frans ^a   Verdouw, Pieter D ^a   Van Den Meiracker, Anton H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin II; Norepinephrine; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN; NORADRENALIN;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG INFUSION; ENZYME ACTIVITY; FEMALE; HEART; HEART LEFT VENTRICLE; HEART MUSCLE; HORMONE BLOOD LEVEL; INTERSTITIAL FLUID; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICRODIALYSIS; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL;

ANGIOTENSIN II; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; HEART; HEMODYNAMIC PROCESSES; INFUSIONS, INTRA-ARTERIAL; KINETICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NOREPINEPHRINE; SWINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0036791785     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000031800.83899.EC     Document Type: Article

References (36)

1. Storgaard T, Nedergaard OA. Prejunctional modulation by angiotensins of noradrenaline release from sympathetic neurons in isolated rabbit aorta. Naunyn Schmiedebergs Arch Pharmacol. 1997;356:706-711.
2. Brasch H, Sieroslawski L, Dominiak P. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension. 1993;22:699-704.
3. Dendorfer A, Raasch W, Tempel K, Dominiak P. Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Bas Res Cardiol. 1998;93:24-29.
4. Teisman AC, Westerink BH, van Veldhuisen DJ, Scholtens E, de Zeeuw D, van Gilst WH. Direct interaction between the sympathetic and reninangiotensin system in myocardial tissue: a microdialysis study in anaesthetised rats. J Auton Nerv Syst. 2000;78:117-121.
5. Abadie C, Foucart S, Page P, Nadeau R. Modulation of noradrenaline release from isolated human atrial appendages. J Auton Nerv Syst. 1996;61:269-276.
6. Clemson B, Gaul L, Gubin SS, Campsey DM, McConville J, Nussberger J, Zelis R. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J Clin Invest. 1994;93:684-691.
7. Saino A, Pomidossi G, Perondi R. Valentini R, Rimini A, Di Francesco L, Mancia G. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans. Circulation. 1997;96:148-153.
8. Rundqvist B, Eisenhofer G, Emanuelsson H, Albertsson P, Friberg P. Intracoronary blockade of angiotensin-converting enzyme in humans: interaction with cardiac sympathetic neurotransmission? Acta Physiol Scand. 1997;161:15-22.
9. Goldsmith SR, Hasking GJ. Effect of a pressor infusion of angiotensin II on sympathetic activity and heart rate in normal humans. Circ Res. 1991;68:263-268.
10. Goldsmith SR, Rector TS, Bank AJ, Garr M, Kubo SH. Effect of angiotensin II on noradrenaline release in the human forearm. Cardiovasc Res. 1994;28:663-666.
11. Chang PC, Grossman E, Kopin IJ, Goldstein DS, Folio CJ, Holmes C. On the existence of functional angiotensin II receptors on vascular sympathetic nerve terminals in the human forearm. J Hypertens. 1995;13:1275-1284.
12. Goldsmith SR. Hasking GJ, Miller E. Angiotensin II and sympathetic activity in patients with congestive heart failure. J Am Coll Cardiol. 1993;21:1107-1113.
13. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Jensen G, Friberg P. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension. Hypertension. 2000;36:543-548.
14. van Kats JP, Danser AH, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MA. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation. 1998;98:73-81.
15. Saino A, Pomidossi G, Perondi R, Morganti A, Turolo L, Mancia G. Modulation of sympathetic coronary vasoconstriction by cardiac reninangiotensin system in human coronary heart disease. Circulation. 2000;101:2277-2283.
16. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990;82:1730-1736.
17. Daly PA, Sole MJ. Myocardial catecholamines and the pathophysiology of heart failure. Circulation. 1990;82:I35-I43.
18. Kawai H, Stevens SY, Liang C-S. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure. Am J Physiol. 2000;279:H3012-H3019.
19. Lameris TW, van den Meiracker AH, Boomsma F, Alberts G, de Zeeuw S, Duncker DJ, Verdouw PD, Veld AJ. Catecholamine handling in the porcine heart: a microdialysis approach. Am J Physiol. 1999;277:H1562-H1569.
20. Lameris TW, de Zeeuw S, Alberts G, Boomsma F, Duncker DJ, Verdouw PD, Veld AJ, van den Meiracker AH. Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation. 2000;101:2645-2650.
21. Yamazaki T, Akiyama T, Kitagawa H, Takauchi Y, Kawada T, Sunagawa K. A new, concise dialysis approach to assessment of cardiac sympathetic nerve terminal abnormalities. Am J Physiol. 1997:272:H1182-H1187.
22. Gunasegaram S, Haworth RS, Hearse DJ, Avkiran M. Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors. Circ Res. 1999;85:919-930.
23. Maruyama R, Hatta E, Yasuda K, Smith NC, Levi R. Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors. J Pharmacol Exp Ther. 2000;294:248-254.
24. Gootman PM, Gandhi MR, Coren CV, Kaplan NM, Pisana FM, Buckley BJ, Armour JA, Gootman N. Cardiac responses elicited by stimulation of loci within stellate ganglia of developing swine. J Auton Nerv Syst. 1992;38:191-200.
25. Alberts G, Lameris T, van den Meiracker AH, Veld AJ, Boomsma F. Sensitive and specific method for the simultaneous determination of natural and synthetic catecholamines and 3,4-dihydroxyphenylglycol in microdialysis samples. J Chromatogr B Biomed Sci Appl. 1999;730:213-219.
26. van Kats JP, Duncker DJ. Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R, Boomsma F, Schalekamp MADH, Verdouw PD, Danser AHJ. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent remodeling in pigs after myocardial infarction. Role of tissue angiotensin II. Circulation. 2000;102:1556-1563.
27. Khairallah PA, Davila D, Papanicolaou N, Glende NM, Meyer P. Effects of angiotensin infusion on catecholamine uptake and reactivity in blood vessels. Circ Res. 1971;28(suppl 2):96-106.
28. Carlsson L, Abrahamsson T. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium. Eur J Pharmacol. 1989;166:157-164.
29. Maruyama R, Hatta E, Levi R. Norepinephrine release and ventricular fibrillation in myocardial ischemia/reperfusion: roles of angiotensin and bradykinin. J Cardiovasc Pharmacol, 1999;34:913-915.
30. Benedict CR, Francis GS, Shelton B, Johnstone DE, Kubo SH, Kirlin P, Nicklas J, Liang CS, Konstam MA, Greenberg B. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators. Am J Cardiol. 1995;75:1151-1157.
31. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation. 1997;96:1173-1179.
32. Schwieler JH, Kahan T, Nussberger J, Hjemdahl P. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms. Am J Physiol. 1993;264:E631-E637.
33. Derad I, Willeke K, Pietrowsky R, Born J, Fehm HL. Intranasal angiotensin II directly influences central nervous regulation of blood pressure. Am J Hypertens. 1998;11:971-977.
34. Porter JP. Contribution of central ANG II to acute stress-induced changes in baroreflex function in young rats. Am J Physiol. 2000;279: R1386-R1391.
35. Kooner JS, May CN, Peart S, Mathias CJ. Separation of peripheral and central cardiovascular actions of angiotensin II. Am J Physiol. 1997;273:H2620-H2626.
36. Matsumoto T, Ozono R, Oshima T, Matsuura H, Sueda T, Kajiyama G, Kambe M, Malendowicz SL, Ennezat PV, Testa M, Murray L, Sonnenblick EH, Evans T, LeJemtel TH, White HL, Hall AS, Bohm M, Zolk O, Flesch M, Schiffer F, Schnabel P, Stasch JP, Knorr A. Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure. Cardiovasc Res. 2000;46:73-81.